Download

Free Med Pocket Cards

Rationale of the Week | Grandfather Avoiding Bolus Insulin

For last week’s practice question, we quizzed participants on insulin. 96% of respondents chose the best answer. We want to clarify and share this important information, so you can pass it on to people living with diabetes and your colleagues, plus prepare for exam success!

Before we start though, if you don’t want any spoilers and haven’t tried the question yet, you can answer it below: Answer Question

Lightbulb and text: Rationale of the Week

R.S. is a 60-year-old with type 2 diabetes who was recently placed on insulin lispro at meals.  He has taken insulin glargine once a day for five years. Previously, non-insulin medications have been ineffective or not tolerated. He continues to have hyperglycemia despite the addition of insulin lispro.  During his diabetes education visit today, he shared that he has not been taking his mealtime insulin lispro because he does not want to inject it in front of his grandchildren, who live with him.  He feels overwhelmed by these additional injections but wants to get his blood glucose levels under better control so he can have the energy to play with his grandchildren and avoid losing his eyesight like his mother did.

As the diabetes care and education specialist, which of the following would be the most appropriate first step in addressing R.S.’s concerns? 

  1. Stress with R.S. the importance of never missing his meal time lispro to prevent diabetes-related complications.
  2. Using open-ended questions, explore R.S.’s routine, stressors, and support systems to understand the barriers to his insulin use.
  3. Recommend R.S. switch to another non-insulin medication to make his regimen easier for him to manage.
  4. Since it appears R.S. did not understand how to take his insulin lispro, write out step-by-step instructions on how to take the insulin.

Getting to the Best Answer

If you are thinking about taking the certification exam, this practice test question will set you up for success. Test writers anticipate possible answers based on the details in the question. They will wave those “juicy answers” right under your nose. Your job is to weed through the particulars, pluck out the most important elements and choose the BEST answer.

Answer A is incorrect: 1% chose this answer, “Stress with R.S. the importance of never missing his meal time lispro to prevent diabetes-related complications.” R.S. is aware that his glycemic control is important, and he is already aware of the risk of diabetes-related complications. Counseling him on this would not help him be successful with his insulin management.  

Answer B is correct: 96% chose this answer, “Using open-ended questions, explore R.S.’s routine, stressors, and support systems to understand the barriers to his insulin use.” R.S. is struggling with barriers to successful insulin management.  A holistic approach would be to ask open-ended questions about his current routine, stressors, and support systems to gain a better understanding of these barriers. This information can lead to a personalized plan of care to help improve glycemic control. 

Answer C is incorrect: 2% chose this answer, “Recommend R.S. switch to another non-insulin medication to make his regimen easier for him to manage.” He has already attempted other non-insulin therapies, and these were either ineffective or not tolerated. Changing his regimen would not be successful at improving his glycemic control and quality of life.

Answer D is incorrect: 1% chose this answer, “Since it appears R.S. did not understand how to take his insulin lispro, write out step-by-step instructions on how to take the insulin.” R.S. appears to understand how to take his insulin lispro at meals. Writing out the instructions would not improve his situation. It is not a lack of knowledge, but the multiple barriers in his life that are keeping him from being able to implement this new medication regimen.  

We hope you appreciate this week’s rationale! Thank you so much for taking the time to answer our Question of the Week and participate in this fun learning activity!

Invite a colleague to our DiabetesEd Seminar in San Diego and get $75 off each registration.

Use code FriendDiscountSD during check out to save. 

Join us live in San Diego October 22nd – 23rd, 2025 for our upcoming

DiabetesEd Training Seminar

30+ CEs with Expanded Accreditation!

Join our expert team for engaging, interactive sessions that bring the ADA Standards of Care to life—covering medications, behavior change, technology, and more. Ideal for CDCES or BC-ADM exam prep, this course also includes a 4-hour Virtual Medical Nutrition Therapy Toolkit and bonus content that also meets CDCES renewal requirements.

Program Objectives:

Upon completion of this activity, participants should be able to:

  • Describe the current ADA Standards for diagnosis, goals, and person-centered diabetes management across the lifespan. 
  • Demonstrate insulin pattern management and dosing strategies in clinical scenarios.
  • Implement timely screening and risk reduction strategies for microvascular and cardiovascular complications.  
  • Incorporate behavior change techniques and medical nutrition therapy to support people with diabetes self-management and lifestyle adjustment.  

Expert Faculty:

Diana Isaacs, PharmD, BCPS, BCACP, CDCES, BC-ADM, FADCES, FCCPCES

Smiling woman in white blazer and lavender blouse

Beverly Thomassian, RN, MPH, CDCES, BC-ADM

Faculty Bios & Disclosures

Our expert team transforms complex diabetes science into clear, practical insights—keeping it real, engaging, and fun!

Program Faculty Disclosures:

Partners for Advancing Clinical Education (Partners) requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to Partners policies. Others involved in the planning of this activity have no relevant financial relationships.

Faculy Bios & Disclosures:

Coach Beverly Thomassian RN, MPH, CDCES, BC-ADM – CEO of DiabetesEd Services

Disclosures: 

Beverly Thomassian has no financial disclosures

Bio:

Author, Nurse, Educator, Clinician, and Innovator, Beverly has specialized in diabetes management for over twenty years. As president and founder of Diabetes Education Services, Beverly is dedicated to providing compassionate and evidence based diabetes education and improving the lives of those with diabetes.

PicsArt_04 03 11Diana Isaacs, PharmD, BCPS, BCACP, CDCES, BC-ADM, FADCES, FCCPCES 

Disclosures:

Dr. Diana Isaacs has the following relevant financial relationships:

  • Consultant, advisor, and speaker for Abbot Labratories, Dexcom, Medtronic, Insulet, Lilly, Cequr, Sanofi, and Undermyfork
  • Board member at Association for Diabetes Care and Education Specialists

Bio:

Diana Isaacs was awarded 2020 ADCES Diabetes Educator of the Year for her educational platform promoting the use of CGM for people with diabetes and other innovations.  She serves in leadership roles for several pharmacies and diabetes organizations. She has numerous diabetes publications and research projects with a focus on medications, CGM and diabetes technology.

For the past three year, Dr. Isaacs has served as a contributing author for the 2023 ADA Standards of Care.

As the Program Coordinator and clinical pharmacist specialist in the Cleveland Clinic Diabetes Center, Dr. Isaacs brings a wealth of clinical knowledge combined with extensive research and speaking experience to this program. 

Activity Start and End Date: 10/22/25 – 10/23/2025

Estimated time to complete the activity: 15 hours and 30 minutes

_____________________________________

Jointly provided by Partners for Advancing Clinical Education and Diabetes Education Services



Joint Accreditation Statement:

 In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (Partners) and Diabetes Education Services. Partners is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Education:

Partners designates this enduring material for a maximum of 15.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development:

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 15.50 contact hours.

Pharmacy Continuing Education:

Partners designates this continuing education activity for 15.50 contact hour(s) (1.550 CEUs) of the Accreditation Council for Pharmacy Education.
(Universal Activity Number – JA4008073-9999-25-206-L01-P)
Type of Activity: Application

For Pharmacists: Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 4 weeks.

Dietitian Continuing Education:

This program offers 15.50 CPEUs for dietitians.

Interprofessional Continuing Education:

This activity was planned by and for the healthcare team, and learners will receive 15.50 Interprofessional Continuing Education (IPCE) credit for learning and change.

For additional information about the accreditation of this activity, please visit https://partnersed.com.

The use of DES products does not guarantee the successful passage of the certification exam. CBDCE and ADCES do not endorse any preparatory or review materials for the CDCES or BC-ADM exams, except for those published by CBDCE & ADCES.

Rationale of the Week | The Power of Medical Nutrition Therapy (MNT)

For last week’s practice question, we quizzed participants on SJ having questions about their insulin pen, and what would be the best response. % of respondents chose the best answer. We want to clarify and share this important information, so you can pass it on to people living with diabetes and your colleagues, plus prepare for exam success!

Before we start though, if you don’t want any spoilers and haven’t tried the question yet, you can answer it below: Answer Question

Lightbulb and text: Rationale of the Week

SJ is 52 years old with a 10-year history of type 2 diabetes. They recently started on insulin degludec U-100 Flex Touch pen 15 units per day. At a follow-up visit, SJ brings their insulin pen and mentions they have been keeping it in their work bag since starting therapy. They are unsure how long they can continue to use this same pen.

What is the best advice for SJ for insulin storage in this situation?

  1. “It is recommended that insulin is always stored and kept refrigerated. Can you make sure you pack your insulin with your lunch cooler pack?”
  2. “Consider storing insulin in your freezer to allow it to be kept cold and protected when refrigeration is less reliable.”
  3. “If bringing your insulin with you every day helps you remember to take it, it should be okay to leave the pen you’re using in your workbag when at the office or at home.”
  4. “Once open, insulin pens can be stored and used at room temperature for up to 28 days, you should be okay with bringing it with you in your work bag.”

Getting to the Best Answer

If you are thinking about taking the certification exam, this practice test question will set you up for success. Test writers anticipate possible answers based on the details in the question. They will wave those “juicy answers” right under your nose. Your job is to weed through the particulars, pluck out the most important elements and choose the BEST answer.

Answer A is incorrect: % chose this answer, “It is recommended that insulin is always stored and kept refrigerated. Can you make
sure you pack your insulin with your lunch cooler pack?” While refrigeration is ideal for insulin storage, insulin does not always need to be refrigerated. Once in use, most insulins, including degludec, are stable at room temperature (below 86F or 30 C). Advising refrigeration may create unnecessary barriers and does not reflect degludec’s stability profile.

Answer B is incorrect: % chose this answer, “Consider storing insulin in your freezer to allow it to be kept cold and protected when
refrigeration is less reliable.” Freezing damages insulin molecules, making the insulin ineffective and unsafe to use. This option contradicts manufacturer and clinical safety guidance.

Answer C is correct: % chose this answer, “If bringing your insulin with you every day helps you remember to take it, it should be
okay to leave the pen you’re using in your workbag when at the office or at home.” Insulin degludec is stable at room temperature below 86°F (30°C) for up to 56 days (8 weeks) once opened. If SJ’s work bag is not exposed to excessive heat or freezing, keeping the pen there is acceptable and may in fact support consistent dosing. We can also calculate SJ’s monthly insulin pen usage (15 units per day + 2 unit prime per injection = 510 units per month or 2 pens per month), knowing he will easily use more insulin than open insulin pen stability time window.

Answer D is incorrect: % chose this answer, “Once open, insulin pens can be stored and used at room temperature for up to 28 days, you should be okay with bringing it with you in your work bag.” While it is correct that insulin does not always require refrigeration once in use, the specific duration varies by insulin type; degludec lasts longer than 28 days.

To learn more, check out our Insulin Storage Cheat Sheet.

We hope you appreciate this week’s rationale! Thank you so much for taking the time to answer our Question of the Week and participate in this fun learning activity!

Learn More From Our Nutrition Expert

Level 1 Diabetes Fundamentals

6 Session Series Starts On January 7th, 2026

Question of the Week | The Power of Medical Nutrition Therapy (MNT)

Question of the Week Diabetes Education Services

SJ is 52 years old with a 10-year history of type 2 diabetes. They recently started on insulin degludec U-100 Flex Touch pen 15 units per day. At a follow-up visit, SJ brings their insulin pen and mentions they have been keeping it in their work bag since starting therapy. They are unsure how long they can continue to use this same pen.

What is the best advice for SJ for insulin storage in this situation?

  1. “It is recommended that insulin is always stored and kept refrigerated. Can you make sure you pack your insulin with your lunch cooler pack?”
  2. “Consider storing insulin in your freezer to allow it to be kept cold and protected when refrigeration is less reliable.”
  3. “If bringing your insulin with you every day helps you remember to take it, it should be okay to leave the pen you’re using in your workbag when at the office or at home.”
  4. “Once open, insulin pens can be stored and used at room temperature for up to 28 days, you should be okay with bringing it with you in your work bag.”

Learn More From Our Nutrition Expert

Level 1 Diabetes Fundamentals

6 Session Series Starts On January 7th, 2026

The Power of Medical Nutrition Therapy (MNT)

What is MNT, and how is it beneficial?

Medical Nutrition Therapy (MNT) is effective because it is both
personalized and evidence-based. It can adapt to an individual while being guided by care standards. MNT is defined as a nutrition-based treatment delivered by a Registered Dietitian Nutritionist (or other qualified health professional) for the prevention, treatment and management of medical conditions. It includes nutrition assessment, diagnosis, therapeutic and counseling interventions, monitoring of outcomes, and coordination with care teams. ¹

The nutrition care process can be applied across a wide range of settings, from community, outpatient clinics, hospitals, private practice, long‐term care, telehealth, and more. A recent position paper ², released before publication in the Journal of the Academy of Nutrition and Dietetics, highlighted the effectiveness of MNT in the Prevention and Treatment of Chronic Diseases. They found that despite evidence of the benefit of RDN-delivered nutrition interventions for many chronic conditions, significant
barriers remain in reimbursement, referral processes, and access to care.

Can MNT Be Covered By Insurance?

Coverage for MNT in the United States varies considerably by payer type. Federally, for Medicare Part B, MNT is covered when a beneficiary has diabetes, non-dialysis chronic kidney disease (stage 3-5), or has had a kidney transplant within the past 36 months. A Medicare-enrolled RDN can schedule and bill for services after obtaining a physician signed (MD or DO) referral, at this time mid-level providers currently do not qualify to sign MNT referrals for Medicare benefit. Medicare provides for up to three hours of MNT in the first year of referral and up to two hours in each subsequent year (with allowance for additional hours if deemed medically necessary). ³ As of January 2025, RDNs can also bill for Direct Training Caregiver Services, which means they can provide education and training to unpaid caregivers who help with tasks like meal preparation and wound care. ²

Medicaid programs are financed by both the state and federal governments, but each state can determine its own coverage and
reimbursement for specific services. State Medicaid programs exhibit significant variability in their coverage and reimbursement rates for MNT services. A recent mapping project by the Academy of Nutrition and Dietetics 4 found that while 37 states recognize MNT billing codes, in only 26 states can RDNs enroll as Medicaid providers (one additional state for pediatric services only), and in only 23 states can RDNs bill independently (others can bill incident-to services). Coverage for MNT services also varies, with some limiting depending on the diagnosis to other states providing reimbursement for a broad range of preventive and medical nutrition therapy. 5

Commercial insurance plans also vary widely in their benefit structure, with some limiting coverage while others extending beyond Medicare-covered diabetes and CKD to also include pre-diabetes, obesity, malnutrition, cardiovascular disease (including hypertension and dyslipidemia), cancer, eating disorders, gastrointestinal conditions, and more.

Although some plans have expanded their coverage, it is not universal and understanding coverage requires knowing an individual’s insurance plan benefits, the RDN network status, diagnosis and referral requirements, the number of covered visits/hours/units, medical or preventive benefit coverage, and, if applicable, telehealth eligibility. Benefits can change annually, and reimbursement rates can also vary widely depending on the state and payer.

When the Affordable Care Act was implemented in 2010 it help provide premium subsidies and increased coverage of preventive and chronic disease services. This led to an increase in MNT coverage expectation and waived share-of-cost for individuals receiving MNT. However, in practice, coverage remains patchwork, with substantial variability in approved diagnoses, covered hours, cost-sharing requirements, and provider networks across plans.

Why MNT Is Important

Coordinated care and collaboration are essential for managing chronic conditions, and timely referrals to MNT play a key role in this process. Deciding when to refer should follow disease or area-specific screening criteria (such as validated malnutrition screenings) or as per the Standards of Care in Diabetes, should occur at diagnosis, annually, and whenever treatment goals are unmet, complications develop, or significant life transitions take place. 6

While referral protocols can streamline MNT referrals, access to RDNs remains a challenge in many communities and is further complicated by the need to understand differences in Medicare, Medicaid, and commercial payer coverage so individuals can fully benefit from available services.

How Can I Help?

Healthcare providers can support individuals receiving care by helping them interpret their plan’s benefits, identify coverage barriers (including limited preventive coverage within Medicare and some Medicaid and commercial plans), and connect them to alternative or complementary resources such as Diabetes Prevention or DSMES programs, community health initiatives, or sliding-scale RDN services when MNT is not covered. Providers can also increase their awareness of policy and advocacy efforts to expand MNT benefit eligibility. ⁷ By working together, the entire care team can strengthen care coordination, enhance access to nutrition services, and support the implementation of MNT to improve our population’s health.

References: 

  1. Medical-Nutrition-Therapy. Downloaded from
    https://www.eatrightpro.org/career/payment/medical-nutrition-therapy on November 17, 2025.
  2. Moloney L, Rozga M, Steiber A, Handu D, The Effectiveness of Medical Nutrition Therapy in Prevention and Treatment of Chronic Disease: A Position Paper of the Academy of Nutrition and Dietetics. Journal of the Academy of Nutrition and Dietetics. 2025. doi: https://doi.org/10.1016/j.jand.2025.10.010
  3. CMS: National Coverage Determination. Downloaded from https://www.cms.gov/medicare-coverage-database/view/ncd.aspx?ncdid=252 on November 17th, 2025.
  4. Mapping Medicaid Coverage for Medical Nutrition Therapy: Why Access Matters. Downloaded from https://www.eatrightpro.org/news-center/public-policy-news/mapping-medicaid-coverage-for-medical-
    nutrition-therapy-why-access-matters on November 17th, 2025.
  5. Markus A, Léon C, Blankenship J. Integrating Registered Dietitian Nutritionists’ Medical Nutrition Therapy Benefit Into Existing State Medicaid Coverage and Reimbursement Policy: Results From a Nationwide Medicaid Medical Nutrition Therapy Mapping Project. Journal of the Academy of Nutrition and Dietetics. 2025, SSN 2212-2672. https://doi.org/10.1016/j.jand.2025.08.009.
  6. American Diabetes Association Professional Practice Committee; 5. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes: Standards of Care in Diabetes—2025. Diabetes Care 1 January 2025; 48 (Supplement_1): S86-S127. https://doi.org/10.2337/dc25-S005
  7. MNT Act. Downloaded from https://www.eatrightpro.org/advocacy/federal-policy-initiatives/all-legislation/medical-nutrition-therapy-act on November 17th, 2025.

Learn More From Our Nutrition Expert!

Level 1 Diabetes Fundamentals

6 Session Series Starting on January 7th, 2026

Rationale of the Week | Keeping You in the Loop: twiist Insulin Pump

For last week’s practice question, we quizzed participants on RT forgetting their insulin, and what would be the best response. % of respondents chose the best answer. We want to clarify and share this important information, so you can pass it on to people living with diabetes and your colleagues, plus prepare for exam success!

Before we start though, if you don’t want any spoilers and haven’t tried the question yet, you can answer it below: Answer Question

Lightbulb and text: Rationale of the Week

Grace is a 38-year-old female who has lived with type 1 diabetes for 20 years. She is a nurse and works variable shifts. She voices concern today about her hemoglobin A1c being elevated at 8.4% over the past 6 months. She is doing everything she can to manage her diet, daily exercise routine, and reports rarely missing insulin doses. She is currently using a Dexcom G7 CGM.

She has never pursued insulin pump therapy because she was fearful that she would no longer be in control of her diabetes if she used a pump. She is now interested in an automated insulin delivery system and asks you which pump is “best” for controlling blood sugar.

What is the best way to answer this question?

  1. Discuss the insulin pump options that connect with the Dexcom G7 CGM. This will help simplify her transition to pump therapy by minimizing the learning curve when starting an AID system.
  2. Acknowledge Grace’s interest in insulin pump technology and recommend that she wait until more advanced insulin pump algorithms are available that are easier to use.
  3. Recommend that Grace use a tubeless pump as it will suit her better due to her work as a nurse and active lifestyle. This will help to avoid tubing issues or the insertion site becoming dislodged.
  4. Review with Grace the details of all the available insulin pumps, algorithms, and compatible CGMs so she can make a personalized decision based on her preferences and lifestyle.

Getting to the Best Answer

If you are thinking about taking the certification exam, this practice test question will set you up for success. Test writers anticipate possible answers based on the details in the question. They will wave those “juicy answers” right under your nose. Your job is to weed through the particulars, pluck out the most important elements and choose the BEST answer.

Answer A is incorrect: % chose this answer, “Discuss the insulin pump options that connect with the Dexcom G7 CGM. This will help simplify her transition to pump therapy by minimizing the learning curve when starting an AID system.” Although some insulin pumps are compatible with the Dexcom CGM, switching to a different CGM supplier should not restrict clients from selecting the insulin pump that best suits their needs.

Answer B is incorrect: % chose this answer, “Acknowledge Grace’s interest in insulin pump technology and recommend that she wait until more advanced insulin pump algorithms are available that are easier to use.” Automated insulin delivery systems offer advanced automation. Waiting for future technology will not help Grace improve glycemic control now.

Answer C is incorrect: % chose this answer, “Recommend that Grace use a tubeless pump as it will suit her better due to her work as a nurse and active lifestyle. This will help to avoid tubing issues or the insertion site becoming dislodged.” The type of pump, with or without tubing, is a personal decision and is not based solely on occupation.

Answer D is correct: % chose this answer, “Review with Grace the details of all the available insulin pumps, algorithms, and compatible CGMs so she can make a personalized decision based on her preferences and lifestyle.” Choosing the right insulin pump is a highly personalized decision. Each insulin pump has different variables and CGM connectivity that must be considered. Grace will need to be educated on the available options so she can determine which insulin pump will work best for her.

We hope you appreciate this week’s rationale! Thank you so much for taking the time to answer our Question of the Week and participate in this fun learning activity!

Cyber Weekend Sale!

Course credits through AMA PRA Category 1 Credits™, ACPE, ANCC, and CDR!

Use the code Cyber30 from Nov. 30th to Dec. 2nd for 30% off your entire order of online university courses and extensions!

Rationale of the Week | MS keeps getting UTI’s – Best action?

For last week’s practice question, we quizzed participants on MS continuously getting UTIs, and what would be the best response. % of respondents chose the best answer. We want to clarify and share this important information, so you can pass it on to people living with diabetes and your colleagues, plus prepare for exam success!

Before we start though, if you don’t want any spoilers and haven’t tried the question yet, you can answer it below: Answer Question

Lightbulb and text: Rationale of the Week

MS is a 59-year-old with type 2 diabetes who is struggling with frequent urinary tract infections. They are on metformin and empagliflozin, and their A1C is 7.3%. MS has already received several courses of antibiotics.

Which of the following actions would you recommend?

  1. Drink sugar-free cranberry juice a few times a week.
  2. Apply topical vaginal estrogen cream.
  3. Get A1C below 7% by adding basal insulin.
  4. Evaluate MS for autoimmune conditions.

Getting to the Best Answer

If you are thinking about taking the certification exam, this practice test question will set you up for success. Test writers anticipate possible answers based on the details in the question. They will wave those “juicy answers” right under your nose. Your job is to weed through the particulars, pluck out the most important elements and choose the BEST answer.

Answer A is incorrect: % chose this answer, “Drink sugar-free cranberry juice a few times a week.” Scientific studies have yielded mixed and inconsistent results regarding the effectiveness of cranberry juice for prevention. MS needs an intervention that will provide ongoing relief.

Answer B is correct: % chose this answer, “Apply topical vaginal estrogen cream.” Vaginal estrogen cream can help prevent recurrent urinary tract infections (UTIs) in postmenopausal women by restoring the health of vaginal and urinary tissues. Estrogen helps restore a healthy vaginal pH, increases beneficial bacteria, and improves circulation, creating an environment that is less hospitable to uropathogens. It is a non-antibiotic option recommended by medical societies and is associated with a significant reduction in rUTIs.

Answer C is incorrect: % chose this answer, “Get A1C below 7% by adding basal insulin.” Getting A1C to target can reduce risk of infections, but MS A1C is already close to target. They need an effective treatment for their frequent UTI’s.

Answer D is incorrect: % chose this answer, “Evaluate MS for autoimmune conditions.” Frequent UTIs are not usually associated with autoimmune conditions. MS needs an effective treatment for their frequent UTI’s.

We hope you appreciate this week’s rationale! Thank you so much for taking the time to answer our Question of the Week and participate in this fun learning activity!

Learn more about HRT and UTIs in our blog “Hormone Replacement Therapy (HRT) – What You Need to Know”

Learn More From Our Expert

Dr. Jill Schramm, DNP, FNP-C, BC-ADM, CDCES

Level 5 | Hot Flashes & Hyperglycemia

Recorded and Ready For Viewing!

Question of the Week | MS keeps getting UTI’s – Best action?

Question of the Week Diabetes Education Services

MS is a 59-year-old with type 2 diabetes who is struggling with frequent urinary tract infections. They are on metformin and empagliflozin, and their A1C is 7.3%.  MS has already received several courses of antibiotics.

Which of the following actions would you recommend?

  1. Drink sugar-free cranberry juice a few times a week.
  2. Apply topical vaginal estrogen cream.
  3. Get A1C below 7% by adding basal insulin.
  4. Evaluate MS for autoimmune conditions.

Read our blog about Hormone Replacement Therapy (HRT) – What You Need to Know to learn more!

Learn More From Our Expert

Dr. Jill Schramm, DNP, FNP-C, BC-ADM, CDCES

Level 5 | Hot Flashes & Hyperglycemia

Recorded and Ready For Viewing!

Diabetes Tech and Distress

The world of diabetes technology is advancing at a record pace. There is no doubt that technology intends to make life with diabetes a bit easier. In the United States, over 50% of adults living with diabetes have experienced some level of diabetes distress.¹ The impact of diabetes technology on mental well-being is complicated. Diabetes technology, including insulin pumps, continuous glucose monitors (CGMs), and connected insulin pens, can either lessen or aggravate diabetes distress.

Understanding Diabetes Distress

The American Diabetes Association (ADA) defines diabetes distress as “significant negative psychological reactions related to emotional burdens and worries specific to an individual’s experience in having to manage a demanding chronic condition such as diabetes.”.²  Diabetes distress is a natural reaction to the daily burden of managing diabetes. Signs of diabetes distress can include avoiding blood glucose monitoring, omitting medications, and struggling to achieve personal hemoglobin A1c targets.

The ADA recommends screening for diabetes distress at least annually. More frequent screening is recommended if clients are not meeting treatment goals, develop diabetes-related complications, and during times of life transitions.²

To access these validated diabetes distress screening tools in English and Spanish, I encourage you to visit this helpful website, DiabetesDistress.org

  • Diabetes Distress Scale (DDS-17)
  • Type 1 Diabetes Distress Scale (T1-DDS)
  • The Type 2-Diabetes Distress Assessment System (T2-DDAS)

Can Technology Improved Diabetes Distress?

Let’s explore how diabetes technology can have a positive impact on diabetes distress.

CGMs: With current CGMs, fewer fingerstick readings are needed to make treatment decisions. CGMs provide information on blood glucose trends and impending hyperglycemia or hypoglycemia, creating more peace of mind. 

Record Keeping: Various forms of diabetes technology can log blood glucose values, insulin doses, site changes, and total daily doses of insulin.  This eliminates the need for clients to worry about detailed record-keeping. 

Automated Insulin Delivery: Automated insulin pumps can decrease decision fatigue by making automated adjustments to both basal and correction insulin doses. This approach to insulin delivery can also benefit individuals with an active lifestyle. Utilizing wearable insulin delivery devices and algorithms can reduce the mental burden of diabetes self-management.

Connectivity: Remote data sharing supports communication with parents, caregivers, and friends to create a diabetes support team. Connectivity with healthcare providers enhances communication with the care team, allowing adjustments to treatment plans between clinic visits. 

Empowerment: The data trends can empower individuals living with diabetes to take control and gain confidence in making and evaluating medication and lifestyle adjustments in response to changes in glycemic control. 

Can Technology Worsen Diabetes Distress?

As diabetes healthcare professionals, it is important to understand how diabetes technology can negatively impact diabetes distress.

❌ Information Overload: Diabetes technology generates an enormous amount of data.  This can cause distress by constantly feeling the need to monitor glucose trends and numbers throughout the day and night, leading to feelings of anxiety and overwhelm.

Alarms: Alarms on diabetes technology are rooted in safety, but for those living with these devices, this can lead to diabetes distress.  Alarms can disrupt sleep or bring unwanted attention from others in public. Erroneous alarms for hyperglycemia or hypoglycemia can cause stress, frustration, and alarm fatigue.

Perfectionism: Diabetes technology provides a continuous insight into glycemic control, which for some can create a need for perfection. Some clients feel like they fail when they don’t reach their time-in-range goal each day. 

Physical Impact: Wearable devices not only carry a psychological burden but can also cause physical distress. Skin irritation and allergic reactions to adhesives cause physical pain and embarrassment. Those who wish to keep diabetes private, wearing a CGM, insulin pump, or other wearable device that puts diabetes on display, causing distress.

Technical issues: Losing connectivity with CGMs or an AID system can cause frustration and make it challenging to achieve optimal glycemic control.  Insurance coverage, prior authorizations, out-of-pocket costs, and access to supplies for diabetes technology can all contribute to or worsen diabetes distress.

Diabetes Healthcare Professionals Help – Recognize and Address

The 7A’s Framework provides a useful interview tool when assessing for Diabetes Distress: 

  1. Aware: Be aware of diabetes distress.
  2. Ask: Ask about diabetes distress. 
  3. Assess: Use a validated screening tool for assessment.
  4. Advise: Explain diabetes distress.
  5. Assist: Develop an action plan.
  6. Assign: If you are not equipped to help, assign the client to another healthcare professional. 
  7. Arrange: Set up follow-up as needed. 3

Here are some other actionable tips you can use to help those with diabetes distress:

  • Refer clients to local or virtual diabetes support groups.
  • Discuss with clients that diabetes distress is common and not a character flaw or failure
  • Collaborate to choose the best technology based on their technology readiness, skill level, and comfort level. 
  • Set realistic goals for time-in-range and other data metrics.
  • Educate clients on how to troubleshoot their devices regarding alarms or connectivity issues. 
  • Support a healthy relationship with diabetes tech.

References

    1. Alexander, D.S., Saelee, R., Betsy Rodriguez, B., Koyama, A. K., Cheng, Y. J., Tang, S., Rutkowski, R. E., & Bullard, K. M. (2025). Diabetes distress among US adults with diagnosed diabetes, 2021. Preventing Chronic Disease: Public Health Research, Practice, and Policy, 22(E07), 1-7. https://www.cdc.gov/pcd/issues/2025/24_0287.htm#:~:text=Among%20US%20adults%20with%20diabetes%2C%20an%20estimated%201.6%20million%20(6.6,income%20compared%20with%20their%20counterparts.

    2. American Diabetes Association Professional Practice Committee. (2025). Facilitating positive health behaviors and well-being to improve health outcomes: Standards of care in diabetes—2025. Diabetes Care, 48(Supplement_1): S86–S127. https://diabetesjournals.org/care/article/48/Supplement_1/S86/157563/5-Facilitating-Positive-Health-Behaviors-and-Well?searchresult=1
    3. American Diabetes Association. (n.d.). Professional development: Behavioral health toolkit. https://professional.diabetes.org/professional-development/behavioral-mental-health/behavioral-health-toolkit
    4. Healing through Connection for Healthcare Professionals by Beverly Thomassian

Cyber Weekend Sale!

30% Off Our Entire Collection of Online University Courses

Course credits through AMA PRA Category 1 Credits™, ACPE, ANCC, and CDR

Diabetes Blog Bytes

Sign up now to receive the latest Blog Bytes in your inbox.

 

Subscribe

* indicates required